AMVGX | MVCAX | AMVGX / MVCAX | |
Total Expense Ratio | 0.78 | 0.99 | 79% |
Annual Report Gross Expense Ratio | 0.78 | 1.00 | 78% |
Fund Existence | 8 years | 24 years | - |
Gain YTD | 4.100 | 1.565 | 262% |
Front Load | N/A | 6% | - |
Min. Initial Investment | 0 | 1000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 6.91B | 16.9B | 41% |
Annual Yield % from dividends | 1.76 | 0.87 | 202% |
Returns for 1 year | 0.82 | -3.41 | -24% |
Returns for 3 years | 6.89 | 14.10 | 49% |
Returns for 5 years | 18.12 | 50.40 | 36% |
Returns for 10 years | N/A | 64.66 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
ASIAX | 29.92 | 0.18 | +0.61% |
Invesco EQV Asia Pacific Equity A | |||
NESYX | 62.69 | 0.09 | +0.14% |
Natixis US Equity Opportunities Y | |||
CGFFX | 81.85 | 0.04 | +0.05% |
American Funds Growth Fund of Amer 529F | |||
VVPSX | 12.24 | -0.03 | -0.24% |
Vulcan Value Partners Small Cap | |||
JFNNX | 65.40 | -0.30 | -0.46% |
Janus Henderson Global Life Sciences N |